IQVIA Holdings Inc. IQV
Set alert
As of Nov 2, 3:52 PM ET
- YTD
- +14.56%
- 1 year
- +19.30%
- Open
- 269.43
- Prev close
- 267.33
- Mkt cap
- 42.55B
- Vol
- 951.17K
- Avg vol
- 1.41M
- EPS
- 8.22
- P/E
- 31.41
- Div yield
- 0.00%
More statistics
- Low
- 257.35
- High
- 270.00
- Forward P/E
- 18.78
- Beta
- 1.17
- Short ratio
- 1.92
- Inst. own
- 103.10%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 4, 2027
- 50-d avg
- 265.87
- 200-d avg
- 209.39
- 1y target
- 309.76
5D chart
Events in this range
- Oct 27, 2026Earnings: 3.34; estimate 3.26; surprise 2.45%
- Oct 28, 2026Rating: Baird · Outperform → Outperform
- Oct 28, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Oct 28, 2026Rating: Truist Securities · Buy → Buy
- Oct 28, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 29, 2026Rating: TD Cowen · Buy → Buy
Signals (121)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Nov 2, 3:30 PM | 22 minutes ago |
| MACD: Sell Signal | Nov 2, 2:35 PM | 1 hour ago |
| SMA: Bearish | Nov 2, 2:30 PM | 1 hour ago |
| SMA: Bearish | Nov 2, 2:25 PM | 1 hour ago |
| SMA: Bullish | Nov 2, 2:10 PM | 1 hour ago |
| SMA: Bearish | Nov 2, 1:55 PM | 1 hour ago |
| SMA: Bullish | Nov 2, 1:50 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 2 hours ago |
| SMA: Bullish | Nov 2, 1:35 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 1:30 PM | 2 hours ago |
| SMA: Bullish | Nov 2, 1:20 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 1:15 PM | 2 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 12:40 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 12:35 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 12:25 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 12:20 PM | 3 hours ago |
| MACD: Buy Signal | Nov 2, 12:10 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 12:05 PM | 3 hours ago |
| RSI: Oversold | Nov 2, 11:50 AM | 4 hours ago |
| SMA: Bearish | Nov 2, 11:35 AM | 4 hours ago |
| SMA: Bullish | Nov 2, 11:30 AM | 4 hours ago |
| SMA: Bearish | Nov 2, 10:25 AM | 5 hours ago |
| SMA: Bullish | Nov 2, 10:20 AM | 5 hours ago |
| SMA: Bearish | Nov 2, 9:40 AM | 6 hours ago |
| MACD: Sell Signal | Nov 2, 9:40 AM | 6 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 6 hours ago |
| SMA: Bullish | Oct 30, 3:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:40 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:20 PM | 3 days ago |
| RSI: Oversold | Oct 30, 12:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 11:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:25 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:15 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 11:15 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:00 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:00 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:55 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:45 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 3 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:45 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 2:45 PM | 4 days ago |
| SMA: Bearish | Oct 29, 2:35 PM | 4 days ago |
| SMA: Bullish | Oct 29, 2:25 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 2:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 2:15 PM | 4 days ago |
| SMA: Bearish | Oct 29, 2:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 2:05 PM | 4 days ago |
| SMA: Bullish | Oct 29, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:55 PM | 4 days ago |
| SMA: Bullish | Oct 29, 1:45 PM | 4 days ago |
| RSI: Oversold | Oct 29, 1:15 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:45 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:45 PM | 4 days ago |
| SMA: Bullish | Oct 29, 12:40 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:05 PM | 4 days ago |
| SMA: Bullish | Oct 29, 11:15 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:10 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:00 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:00 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:25 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:15 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:15 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:30 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:05 PM | 5 days ago |
| SMA: Bearish | Oct 28, 11:55 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:50 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:40 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:10 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 11:10 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:35 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 9:35 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:35 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 3:55 PM | 6 days ago |
| MACD: Sell Signal | Oct 27, 3:45 PM | 6 days ago |
| SMA: Bearish | Oct 27, 3:35 PM | 6 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 6 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 6 days ago |
| SMA: Bearish | Oct 27, 2:20 PM | 6 days ago |
| MACD: Buy Signal | Oct 27, 1:35 PM | 6 days ago |
| SMA: Bullish | Oct 27, 1:30 PM | 6 days ago |
| SMA: Bearish | Oct 27, 11:40 AM | 6 days ago |
| SMA: Bullish | Oct 27, 10:35 AM | 6 days ago |
News
-
4 days ago benzinga.com
TD Cowen Maintains Buy on IQVIA Holdings, Raises Price Target to $307
TD Cowen analyst Charles Rhyee maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $288 to $307.
4 days ago seekingalpha.com
Artisan Global Value Fund Q3 2026 Portfolio Discussion
US government debt-to-GDP exceeds 120%, while annual interest payments now surpass the budget for national defense. Our three best-performing stocks this quarter were Meta, IQVIA and Shell. Our three…
4 days ago zacks.com
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
-
5 days ago benzinga.com
JP Morgan Maintains Overweight on IQVIA Holdings, Raises Price Target to $325
JP Morgan analyst Casey Woodring maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $295 to $325.
-
5 days ago benzinga.com
Truist Securities Maintains Buy on IQVIA Holdings, Raises Price Target to $346
Truist Securities analyst Jailendra Singh maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $329 to $346.
-
5 days ago benzinga.com
Evercore ISI Group Maintains Outperform on IQVIA Holdings, Raises Price Target to $310
Evercore ISI Group analyst Elizabeth Anderson maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $290 to $310.
-
5 days ago benzinga.com
Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $328
Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $324 to $328.
5 days ago defenseworld.net
IQVIA Holdings Inc. $IQV Stock Purchased by Citizens Financial Group Inc. RI
Citizens Financial Group Inc. RI increased its holdings in shares of IQVIA Holdings Inc. (NYSE: IQV) by 67.8% in the third quarter, according to the company in its most recent Form 13F filing with…
6 days ago marketbeat.com
What IQVIA (IQV) Said on Its Q3 Earnings Call
IQVIA NYSE: IQV reported third-quarter results that exceeded the high end of its guidance ranges, supported by accelerating organic growth in its Commercial Solutions and R&D Solutions businesses,…
6 days ago zacks.com
IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y
IQV's Q3'26 earnings beat estimates as revenues rise 8% y/y, led by strong clinical demand, robust R&D bookings and improved execution, prompting a view hike.
6 days ago benzinga.com
IQVIA Hldgs Q3 2026 Earnings Call Transcript
IQVIA Hldgs (NYSE:IQV) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
6 days ago zacks.com
IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates
IQVIA Holdings (IQV) came out with quarterly earnings of $3.34 per share, beating the Zacks Consensus Estimate of $3.24 per share. This compares to earnings of $3 per share a year ago.
6 days ago gurufocus.com
IQVIA Reports Third-Quarter 2026 Results
IQVIA Holdings Inc. (âIQVIAâ) (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the li
-
6 days ago benzinga.com
IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.80-$13.00 to $12.90-$13.00 vs $12.96 Est; Raises FY2026 Sales Guidance from $17.275B-$17.475B to $17.350B-$17.500B vs $17.419B Est
IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.80-$13.00 to $12.90-$13.00 vs $12.96 analyst estimate. Raises FY2026 sales outlook from $17.275 billion-$17.475 billion to $17.350…
6 days ago businesswire.com
IQVIA Reports Third-Quarter 2026 Results
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to…
1 week ago zacks.com
IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know
IQV is poised for y/y revenue and earnings growth in Q3, driven by stronger clinical research demand, solid bookings, AI adoption and operational efficiencies.
1 week ago seekingalpha.com
IQVIA: R&D Bookings Are Reaccelerating, But The Valuation Now Requires Execution
IQVIA Holdings (IQV) is rated Buy, supported by strong Q2 results and a robust R&D bookings recovery. Q2 revenue grew 8.7% to $4.37B, with adjusted EPS up 12.1% and R&D net new bookings surging 19%…
1 week ago zacks.com
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
1 week ago defenseworld.net
IQVIA Holdings Inc. $IQV Stock: Maia Wealth LLC Reduces Stake
Maia Wealth LLC trimmed its position in shares of IQVIA Holdings Inc. (NYSE: IQV) by 44.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange…
2 weeks ago defenseworld.net
First Citizens Bank & Trust Co. Makes New $1.39 Million Investment in IQVIA Holdings Inc. $IQV
First Citizens Bank and Trust Co. acquired a new position in shares of IQVIA Holdings Inc. (NYSE: IQV) in the third quarter, according to its most recent disclosure with the Securities and Exchange…
-
2 weeks ago benzinga.com
Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $303
Stifel analyst Shlomo Rosenbaum maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $276 to $303.
-
2 weeks ago benzinga.com
IQVIA Expands Partnership Veeva Systems On Enterprise Standard Applications That Will Be Used Across IQVIA Clinical Development Studies
IQVIA (NYSE:IQV) and Veeva Systems (NYSE:VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard…
2 weeks ago prnewswire.com
IQVIA Selects Veeva Clinical Operations Applications
RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif.
-
2 weeks ago businesswire.com
IQVIA Selects Veeva Clinical Operations Applications
RESEARCH TRIANGLE PARK, N.C. & PLEASANTON, Calif.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) and Veeva Systems (NYSE: VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS,…
3 weeks ago zacks.com
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 weeks ago businesswire.com
IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and…
3 weeks ago businesswire.com
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and…
-
3 weeks ago benzinga.com
Mizuho Maintains Outperform on IQVIA Holdings, Raises Price Target to $300
Mizuho analyst Ann Hynes maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $275 to $300.
-
3 weeks ago benzinga.com
Barclays Maintains Overweight on IQVIA Holdings, Raises Price Target to $300
Barclays analyst Luke Sergott maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $275 to $300.
1 month ago zacks.com
Extensive Database & Solid Bookings Benefit IQVIA Amid Low Liquidity
IQV's vast healthcare database, AI-enabled capabilities and strong R&DS bookings support growth, while low liquidity and $14.1B net debt remain in focus.
-
1 month ago benzinga.com
RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $319
RBC Capital analyst Ryan Halsted maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $247 to $319.
1 month ago defenseworld.net
Rep. Kevin Hern Unloads Shares of Honeywell International Inc. (NASDAQ:HON)
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Honeywell International Inc. (NASDAQ: HON). In a filing disclosed on September 25th, the Representative disclosed that they had…
-
1 month ago benzinga.com
Truist Securities Reiterates Buy on IQVIA Holdings, Raises Price Target to $329
Truist Securities analyst Jailendra Singh reiterates IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $300 to $329.
-
1 month ago benzinga.com
Morgan Stanley Maintains Equal-Weight on IQVIA Holdings, Raises Price Target to $270
Morgan Stanley analyst Kallum Titchmarsh maintains IQVIA Holdings (NYSE:IQV) with a Equal-Weight and raises the price target from $240 to $270.
-
3 months ago benzinga.com
JP Morgan Maintains Overweight on IQVIA Holdings, Raises Price Target to $285
JP Morgan analyst Casey Woodring maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $225 to $285.
-
3 months ago benzinga.com
Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $276
Stifel analyst Shlomo Rosenbaum maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $220 to $276.
-
3 months ago benzinga.com
TD Cowen Maintains Buy on IQVIA Holdings, Raises Price Target to $288
TD Cowen analyst Charles Rhyee maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $233 to $288.
-
3 months ago benzinga.com
RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $247
RBC Capital analyst Ryan Halsted maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $221 to $247.
-
3 months ago benzinga.com
BMO Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $270
BMO Capital analyst Sean Dodge maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $210 to $270.
-
3 months ago benzinga.com
Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $287
Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $252 to $287.
3 months ago benzinga.com
Nasdaq 100 Enters Correction, SanDisk Sinks Over 50% From Peak: Stock Market Today
A deepening chip rout drags the Nasdaq while Coca-Cola and Sherwin-Williams beats power the Dow; oil dives 5% on Iran diplomacy as the Fed meets.
3 months ago benzinga.com
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday
U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting better-than-expected earnings and raising FY26 guidance.
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million. Prelude Therapeutics (NASDAQ:PRLD)…
-
3 months ago benzinga.com
IQVIA Hldgs Q2 Adj. EPS $3.15 Beats $3.03 Estimate, Sales $4.368B Beat $4.301B Estimate
IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $3.15 per share which beat the analyst consensus estimate of $3.03 by 3.96 percent. This is a 12.1 percent increase over earnings of $2.81 per…
-
3 months ago benzinga.com
IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 Est; Raises FY2026 Sales Guidance from $17.150B-$17.350B to $17.275B-$17.475B vs $17.286B Est
IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 analyst estimate. Raises FY2026 sales outlook from $17.150 billion-$17.350 billion to $17.275…
-
3 months ago benzinga.com
Mizuho Maintains Outperform on IQVIA Holdings, Raises Price Target to $230
Mizuho analyst Ann Hynes maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $215 to $230.
4 months ago benzinga.com
Palo Alto To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, please see our analyst ratings page.
-
4 months ago benzinga.com
Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $249
Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $230 to $249.
4 months ago benzinga.com
Micron To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
Top analysts changed outlook on top names: Intuit downgraded, Alkermes price target raised, Carmax target increased, Sezzle target up, Biogen target raised, Progressive target cut.
-
4 months ago benzinga.com
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed outlook on top names. Baird raised prices for Ryder System and J B Hunt, Needham for Glaukos, B of A for CSX, Morgan Stanley for Charles River, and Bernstein for…